Adaptation of anticancer strategies to progress in XXXX immunology.

@entity1 @entity5 @entity26 @entity1200 @entity3
The numerical development of @entity5 cells during @entity5 growth and under current forms of therapy is quantitatively described as a fundamental of a scientifically founded anticancer strategy. As to general @entity5 prevention, suppression of @entity3 and reduction of recurrencies, figures are derived, which allow one to assess the minimal number of malignant cells to be killed. The killing potency of current @entity1200 has not so far been sufficient enough to have a good chance of achieving these ambitious goals. The main reason for this is the neglect of the @entity26 status of the body and its dynamics. This is a surprising fact, since all immunological mechanisms are known to be energy-, i.e., @entity26 -dependent. The experimentally confirmed correlation between the effectiveness of body defense and the quality of the @entity26 status was the origin of several variants of the @entity26 multistep immunostimulation concept (application of immunostimulators combined with the @entity26 multistep therapy). Clinical results reflect the remarkable increase of cell-killing potency achievable by these measures and give reasons for the adaptation of anticancer strategies to progress in @entity5 immunology. Furthermore, real methodological proposals are made for general @entity5 prevention, suppression of @entity3 , and reduction of recurrences, and the concept of a combined therapy is developed. This therapy comprises the currently accepted measures, such as surgery, irradiation and drugs, and the adjuvant O2 multistep immunostimulation, which is applied threefold according to a particular schedule. The advantage of this combination is that the @entity1 comes first into the enjoyment of all the beneficial effects that established regimens can offer for the particular case. Then and moreover, the @entity1 gains better quality of life, because the adverse side-effects of radiation and drugs are attenuated and, finally, the individual gets a fair chance of stopping the progression of the disease.
